Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies

Journal of Proteome Research

Volumn 13, Issue 6, 2014, Pages 2986-2997

  Zhu, Jianhui ^a   Lin, Zhenxin ^a   Wu, Jing ^a   Yin, Haidi ^a   Dai, Jianliang ^b   Feng, Ziding ^b   Marrero, Jorge ^c   Lubman, David M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

biomarker; fucosylation; haptoglobin; Hepatocellular carcinoma; liver cirrhosis; MALDI

Indexed keywords

BIOLOGICAL MARKER; GLYCAN; HAPTOGLOBIN; MONOCLONAL ANTIBODY; FUCOSE; HP PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; DEGLYCOSYLATION; ELISA KIT; FEMALE; FUCOSYLATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; IMMUNOPRECIPITATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METHYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; PROTEOMICS; QUANTITATIVE ANALYSIS; ADVERSE EFFECTS; BLOOD; CARBOHYDRATE ANALYSIS; CARCINOMA, HEPATOCELLULAR; CASE CONTROL STUDY; COMPLICATION; CONFORMATION; DIFFERENTIAL DIAGNOSIS; DRINKING BEHAVIOR; EARLY CANCER DIAGNOSIS; GLYCOSYLATION; HEPATITIS B; HEPATITIS C; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; MOLECULAR GENETICS; PROTEIN PROCESSING;

AGED; ALCOHOL DRINKING; BIOMARKERS, TUMOR; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; EARLY DETECTION OF CANCER; FEMALE; FUCOSE; GLYCOSYLATION; HAPTOGLOBINS; HEPATITIS B; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84902089821     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500128t     Document Type: Article

References (23)

1. Shariff, M. I.; Cox, I. J.; Gomaa, A. I.; Khan, S. A.; Gedroyc, W.; Taylor-Robinson, S. D. Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis and therapeutics Expert Rev. Gastroenterol. Hepatol. 2009, 3, 353-367
2. Davis, G. L.; Dempster, J.; Meler, J. D.; Orr, D. W.; Walberg, M. W.; Brown, B.; Berger, B. D.; O'Connor, J. K.; Goldstein, R. M. Hepatocellular carcinoma: management of an increasingly common problem Proceedings (Baylor Univ. Med. Center) 2008, 21, 266-280
3. El-Serag, H. B. Hepatocellular carcinoma: an epidemiologic view J. Clin. Gastroenterol. 2002, 35, S72-S78
4. Sanyal, A. J.; Yoon, S. K.; Lencioni, R. The etiology of hepatocellular carcinoma and consequences for treatment Oncologist 2010, 15, 14-22
5. Wang, M.; Long, R. E.; Comunale, M. A.; Junaidi, O.; Marrero, J.; Di Bisceglie, A. M.; Block, T. M.; Mehta, A. S. Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma Cancer Epidemiol., Biomarkers Prev. 2009, 18, 1914-1921
6. Li, D.; Mallory, T.; Satomura, S. AFP-L3: a new generation of tumor marker for hepatocellular carcinoma Clin. Chim. Acta 2001, 313, 15-19
7. Arrieta, O.; Cacho, B.; Morales-Espinosa, D.; Ruelas-Villavicencio, A.; Flores-Estrada, D.; Hernandez-Pedro, N. The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis BMC Cancer 2007, 7, 28-1-28-9
8. Cheng, H. T.; Chang, Y. H.; Chen, Y. Y.; Lee, T. H.; Tai, D. I.; Lin, D. Y. AFP-L3 in chronic liver diseases with persistent elevation of alpha-fetoprotein J. Chin. Med. Assoc. 2007, 70, 310-317
9. Kumada, T.; Toyoda, H.; Tada, T.; Kiriyama, S.; Tanikawa, M.; Hisanaga, Y.; Kanamori, A.; Tanaka, J.; Kagebayashi, C.; Satomura, S. High-sensitivity Lens culinaris agglutinin-reactive alpha-fetoprotein assay predicts early detection of hepatocellular carcinoma J. Gastroenterol. 2014, 49, 555-563
10. Ang, I. L.; Poon, T. C.; Lai, P. B.; Chan, A. T.; Ngai, S. M.; Hui, A. Y.; Johnson, P. J.; Sung, J. J. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach J. Proteome Res. 2006, 5, 2691-2700
11. Zhang, S.; Shu, H.; Luo, K.; Kang, X.; Zhang, Y.; Lu, H.; Liu, Y. N-linked glycan changes of serum haptoglobin beta chain in liver disease patients Mol. BioSyst. 2011, 7, 1621-1628
12. Dobryszycka, W. Biological functions of haptoglobin-new pieces to an old puzzle Eur. J. Clin. Chem. Clin. Biochem. 1997, 35, 647-654
13. Kurosky, A.; Barnett, D. R.; Lee, T. H.; Touchstone, B.; Hay, R. E.; Arnott, M. S.; Bowman, B. H.; Fitch, W. M. Covalent structure of human haptoglobin: a serine protease homolog Proc. Natl. Acad. Sci. U.S.A. 1980, 77, 3388-3392
14. Okuyama, N.; Ide, Y.; Nakano, M.; Nakagawa, T.; Yamanaka, K.; Moriwaki, K.; Murata, K.; Ohigashi, H.; Yokoyama, S.; Eguchi, H.; Ishikawa, O.; Ito, T.; Kato, M.; Kasahara, A.; Kawano, S.; Gu, J.; Taniguchi, N.; Miyoshi, E. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation Int. J. Cancer 2006, 118, 2803-2808
15. Lin, Z.; Simeone, D. M.; Anderson, M. A.; Brand, R. E.; Xie, X.; Shedden, K. A.; Ruffin, M. T.; Lubman, D. M. Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer J. Proteome Res. 2011, 10, 2602-2611
16. Fujimura, T.; Shinohara, Y.; Tissot, B.; Pang, P. C.; Kurogochi, M.; Saito, S.; Arai, Y.; Sadilek, M.; Murayama, K.; Dell, A.; Nishimura, S.; Hakomori, S. I. Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects Int. J. Cancer 2008, 122, 39-49
17. Park, S. Y.; Yoon, S. J.; Jeong, Y. T.; Kim, J. M.; Kim, J. Y.; Bernert, B.; Ullman, T.; Itzkowitz, S. H.; Kim, J. H.; Hakomori, S. I. N-glycosylation status of beta-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects Int. J. Cancer 2010, 126, 142-155
18. Sanda, M.; Pompach, P.; Brnakova, Z.; Wu, J.; Makambi, K.; Goldman, R. Quantitative liquid chromatography-mass spectrometry-multiple reaction monitoring (LC-MS-MRM) analysis of site-specific glycoforms of haptoglobin in liver disease Mol. Cell. Proteomics 2013, 12, 1294-1305
19. Kang, P.; Mechref, Y.; Klouckova, I.; Novotny, M. V. Solid-phase permethylation of glycans for mass spectrometric analysis Rapid Commun. Mass Spectrom. 2005, 19, 3421-3428
20. Lin, Z.; Lubman, D. M. Permethylated N-glycan analysis with mass spectrometry Methods Mol. Biol. 2013, 1007, 289-300
21. Comunale, M. A.; Wang, M.; Hafner, J.; Krakover, J.; Rodemich, L.; Kopenhaver, B.; Long, R. E.; Junaidi, O.; Bisceglie, A. M.; Block, T. M.; Mehta, A. S. Identification and development of fucosylated glycoproteins as biomarkers of primary hepatocellular carcinoma J. Proteome Res. 2009, 8, 595-602
22. Imre, T.; Kremmer, T.; Heberger, K.; Molnar-Szollosi, E.; Ludanyi, K.; Pocsfalvi, G.; Malorni, A.; Drahos, L.; Vekey, K. Mass spectrometric and linear discriminant analysis of N-glycans of human serum alpha-1-acid glycoprotein in cancer patients and healthy individuals J. Proteomics 2008, 71, 186-197
23. Liu, X. E.; Desmyter, L.; Gao, C. F.; Laroy, W.; Dewaele, S.; Vanhooren, V.; Wang, L.; Zhuang, H.; Callewaert, N.; Libert, C.; Contreras, R.; Chen, C. N-glycomic changes in hepatocellular carcinoma patients with liver cirrhosis induced by hepatitis B virus Hepatology 2007, 46, 1426-1435